Simultaneously, it downregulates cyclins and CDKs, including cyclin D1 and CDK4/6, which are frequently overexpressed in breast cancer and are essential drivers of G1 to S phase transition[26]. The gene discussed is CDK4; the disease is breast carcinoma.